Sort
17,288 grants matching “multiple sclerosis”
MRI Paramagnetic Rim Lesions as Biomarkers and Agents of Neurodegeneration in Multiple Sclerosis
$221,553Christopher C. Hemond · Univ Of Massachusetts Med Sch Worcester · K23 · FY2024 · NS
Targeted Ion Channel Downregulation By Nanoparticles: A Novel Therapeutic approa
$221,444Laura Conforti · University Of Cincinnati · R21 · FY2011 · AR
MOLECULAR BIOLOGY OF CONONAVIRUS INDUCED DEMYELINATION
$221,401University Of Pennsylvania · R01 · FY2002 · NS
Multifunctional Biomaterial for Amelioration of MS in Murine EAE Model
$221,399Julia E Babensee · Georgia Institute Of Technology · R21 · FY2016 · EB
NEUROPATHOLOGY
$221,375Matthew P Frosch · Massachusetts General Hospital · P50 · FY2009 · AG
Development of a dual microparticle platform vaccine system encapsulating immunomodulatory agents and antigen for the amelioration of type 1 diabetes
$221,331Gregory Paul Marshall · Onevax, Llc · R43 · FY2018 · AI
INTERFERON GAMMA EFFECTS ON OLIGODENDROCYTES
$221,326University Of North Carolina Chapel Hill · R01 · FY2000 · NS
Epigenomic regulation of oxidative stress-producing innate immunity in neuroinflammation
$221,306Andrew S Mendiola · University Of California, San Diego · R00 · FY2025 · NS
Antisense oligonucleotides for the treatment of spinocerebellar ataxia type 2
$221,265Daniel R Scoles · University Of Utah · R21 · FY2014 · NS
Regulation of Th17 immune responses by serpinB1
$221,250Eileen Remold-O'Donnell · Boston Children'S Hospital · R21 · FY2017 · AI
Role of Caspase-8 in Neuroinflammation, Demyelination and Myelin Repair
$221,250Jianrong Li · Texas A&M Agrilife Research · R21 · FY2015 · NS
Structure and function of peptide presentation by CD1d
$221,250Dirk M Zajonc · La Jolla Institute For Immunology · R21 · FY2014 · AI
Inhibition of CD38 NADase by anti-CD38 antibody: a novel therapy for systemic scleroderma
$221,204Willem Van Schooten · Teneobio, Inc. · R43 · FY2020 · AR
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis
$221,100Jeffrey R. Bender · Yale University · R21 · FY2021 · AR
Directional Diffusivity as a Window into the Pathology of Multiple Sclerosis (MS)
$221,036Dorothy Anne Cross · Washington University · P01 · FY2009 · NS
Mechanisms underlying neuronal damage in EAE: role of microglia
$221,022Stella Elkabes · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2007 · NS
GABA-B Receptor Modulation of Calcium Currents
$220,952Michelle Mynlieff · Marquette University · R15 · FY2010 · NS
Elucidating the structure-function relationship of LARP6-mediated collagen mRNA transport
$220,945Lisa R Warner · Boise State University · P20 · FY2021 · GM
Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple Sclerosis
$220,875Mireia Guerau-De-Arellano · Ohio State University · R21 · FY2017 · AI
Genetic analysis of endocannabinoid signaling in C. elegans
$220,842Shawn R Lockery · University Of Oregon · R21 · FY2019 · DA
Development of SAgA Therapy for clearance of NMO-IgG in patients with neuromyelit
$220,834Joshua O Sestak · Orion Bioscience, Inc. · R43 · FY2014 · EY
Susceptibility MRI as a marker for diagnosis and clinical disability in MS
$220,821Chunlei Liu · Duke University · R01 · FY2014 · NS
Directional Diffusivity as a Window into the Pathology of Multiple Sclerosis (MS)
$220,819Dorothy Anne Cross · Washington University · P01 · FY2011 · NS
The IRF - type I interferon system in T cell-mediated immune tolerance
$220,717Michael David · University Of California, San Diego · R21 · FY2014 · AI
Stretchable electronic-bladder interface for neuroprosthetic control
$220,704Timothy M. Bruns · University Of Michigan At Ann Arbor · R21 · FY2016 · EB